The make DEEP Human Families Blog

Posts

May 03, 2026

New diabetes clinical trial: Dapagliflozin in Living-Donor Kidney Transplant Recipients

Published on: 2026-04-29T04:00:00Z Conditions : Kidney Transplant; Kidney Transplant Failure Interventions : Drug: Dapagliflozin (10mg Tab); Other: Standard of Care Sponsors : University of Guadalajara; Instituto Mexicano del Seguro Social Active, not recruiting https://ift.tt/sT4JDXu

Search This Blog

The make DEEP Human Families Blog

Posts

UI Health Collaborations and Education

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Dapagliflozin in Living-Donor Kidney Transplant Recipients

Latest Posts

New diabetes clinical trial: Effect of Beetroot Juice on Cardiovascular and Autonomic Responses to Exercise in Adults With Type 2 Diabetes

New diabetes clinical trial: Pemafibrate for Symptomatic ICAS RCT

New diabetes clinical trial: Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy Risk

New diabetes clinical trial: Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Women With Gestational Diabetes

New diabetes clinical trial: Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

New diabetes clinical trial: Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic Patients

New diabetes clinical trial: Effect of Low-Frequency Electroacupuncture on Diabetic Peripheral Neuropathy

New diabetes clinical trial: Goal Commitment and Proactive Health Behavior in Chronic Disease Patients

New diabetes clinical trial: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

New diabetes clinical trial: Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management